KIDRON NADAV

PrivateCIK: 1351779
Location

NEW YORK, NY

KIDRON NADAV (President and CEO) received a stock award from ORAMED PHARMACEUTICALS INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 2 awards
InsiderKIDRON NADAVCIK 1351779
→
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-71.24K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
8
Total transactions
718.26K acquired · 789.50K disposed
Non-Derivative Transactions2

Common Stock

Direct
A · Award

Shares

+349.50K

Price / share

—

Trade value

—

% of position

10.2%
9/24/2026
3.42M→3.77M

Common Stock

Direct
A · Award

Shares

+368.76K

Price / share

—

Trade value

—

% of position

9.8%
9/24/2026
3.77M→4.14M
Total

Net shares

+718.26K

Net value

$0.00

Derivative Transactions6

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

196.50K shares

Shares

−196.50K

Strike price

3.16

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

190K shares

Shares

−190K

Strike price

4.80

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

49K shares

Shares

−49K

Strike price

7.77

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

97K shares

Shares

−97K

Strike price

8.14

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

150K shares

Shares

−150K

Strike price

10.40

Held after

0.00

Exercisable

—

9/24/2026

Stock option (right to buy)

Direct
D · Disposition
Converts to

Common Stock

107K shares

Shares

−107K

Strike price

13.89

Held after

0.00

Exercisable

—

9/24/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned126K
Total
126K indirect126K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
KIDRON NADAV — Insider Transaction (Form 4) Filed Sep 25, 2026 | Finecho